{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:56:52Z","timestamp":1776463012098,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21H02646"],"award-info":[{"award-number":["JP21H02646"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H04283"],"award-info":[{"award-number":["JP22H04283"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K06863"],"award-info":[{"award-number":["JP22K06863"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115504","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T07:30:36Z","timestamp":1694849436000},"page":"115504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Angiogenesis inhibitor-specific hypertension increases the risk of developing aortic dissection"],"prefix":"10.1016","volume":"167","author":[{"given":"Kaito","family":"Tsujinaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-9028","authenticated-orcid":false,"given":"Yuki","family":"Izawa-Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Oomine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honoka","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masateru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syuto","family":"Itokazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsumi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2033-4246","authenticated-orcid":false,"given":"Takahiro","family":"Niimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuka","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Chuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Zamami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1971-7696","authenticated-orcid":false,"given":"Keisuke","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2023.115504_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCOUTCOMES.114.001140","article-title":"Trends in aortic dissection hospitalizations, interventions, and outcomes among medicare beneficiaries in the United States, 2000-2011","volume":"7","author":"Mody","year":"2014","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"issue":"5","key":"10.1016\/j.biopha.2023.115504_bib2","doi-asserted-by":"crossref","first-page":"H1786","DOI":"10.1152\/ajpheart.00229.2020","article-title":"Moderate aerobic exercise prevents matrix degradation and death in a mouse model of aortic dissection and aneurysm","volume":"320","author":"Aicher","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115504_bib3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/hq0701.092136","article-title":"Aortic wall mechanics and composition in a transgenic mouse model of Marfan syndrome","volume":"21","author":"Marque","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115504_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41569-020-00472-6","article-title":"Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes","volume":"18","author":"Bossone","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115504_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/HJH.0000000000001898","article-title":"Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses","volume":"37","author":"Izawa-Ishizawa","year":"2019","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.biopha.2023.115504_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/ATVBAHA.119.313440","article-title":"S-nitrosylation of plastin-3 exacerbates thoracic aortic dissection formation via endothelial barrier dysfunction","volume":"40","author":"Pan","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115504_bib7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/bph.15694","article-title":"The NO signalling pathway in aortic aneurysm and dissection","volume":"179","author":"Toral","year":"2022","journal-title":"Br. J. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2023.115504_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00228-010-0815-4","article-title":"Incidence and risk of significantly raised blood pressure in cancer patients treated with bevacizumab: an updated meta-analysis","volume":"66","author":"An","year":"2010","journal-title":"Eur. J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2023.115504_bib9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/CIRCRESAHA.114.303200","article-title":"Sorafenib cardiotoxicity increases mortality after myocardial infarction","volume":"114","author":"Duran","year":"2014","journal-title":"Circ. Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115504_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","article-title":"Autocrine VEGF signaling is required for vascular homeostasis","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.biopha.2023.115504_bib11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies: the old and the new--an evolving avenue","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2023.115504_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jash.2018.03.008","article-title":"Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events","volume":"12","author":"Touyz","year":"2018","journal-title":"J. Am. Soc. Hypertens."},{"issue":"6","key":"10.1016\/j.biopha.2023.115504_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.semnephrol.2010.09.007","article-title":"Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker","volume":"30","author":"Robinson","year":"2010","journal-title":"Semin Nephrol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115504_bib14","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/cvr\/cvz260","article-title":"Selective ETA vs. dual ETA\/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats","volume":"116","author":"Mirabito Colafella","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115504_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/0284186X.2014.963887","article-title":"Acute aortic dissection in a patient with metastatic renal cell carcinoma treated with axitinib","volume":"54","author":"Niwa","year":"2015","journal-title":"Acta Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115504_bib16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2019.3113","article-title":"Factors associated with immune checkpoint inhibitor-related myocarditis","volume":"5","author":"Zamami","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2023.115504_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3389\/fphar.2019.01257","article-title":"Search for therapeutic agents for cardiac arrest using a drug discovery tool and large-scale medical information database","volume":"10","author":"Zamami","year":"2019","journal-title":"Front Pharm."},{"issue":"19","key":"10.1016\/j.biopha.2023.115504_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197226","article-title":"Preventive effects of quercetin against the onset of atherosclerosis-related acute aortic syndromes in mice","volume":"21","author":"Kondo","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2023.115504_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000492577","article-title":"Nitrosonifedipine, a photodegradation product of nifedipine, suppresses pharmacologically induced aortic aneurysm formation","volume":"102","author":"Imanishi","year":"2018","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115504_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14017431.2019.1689289","article-title":"Inflammatory biomarkers to predict adverse outcomes in postoperative patients with acute type A aortic dissection","volume":"54","author":"Liu","year":"2020","journal-title":"Scand. Cardiovasc J."},{"key":"10.1016\/j.biopha.2023.115504_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110173","article-title":"Sunitinib displays pulmonary fibrosis in experimental rats: Role of IL-17A dependent pathway","volume":"119","author":"Asker","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.115504_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107128","article-title":"Sunitinib malate inhibits intestinal tumor development in male Apc(Min\/+) mice by down-regulating inflammation-related factors with suppressing beta-cateinin\/c-Myc pathway and re-balancing Bcl-6 and Caspase-3","volume":"90","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115504_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10456-022-09863-4","article-title":"Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy","volume":"26","author":"Nowak-Sliwinska","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2023.115504_bib24","article-title":"Insulin resistance and pellino-1 mediated decrease in the activities of vasodilator signaling contributes to sunitinib-induced hypertension","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115504_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/HYPERTENSIONAHA.109.138701","article-title":"Low blood pressure in endothelial cell-specific endothelin 1 knockout mice","volume":"56","author":"Kisanuki","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2023.115504_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/HYPERTENSIONAHA.111.173559","article-title":"The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like syndrome with activation of the endothelin system","volume":"58","author":"Kappers","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2023.115504_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41401-019-0331-8","article-title":"PK\/PD modeling based on NO-ET homeostasis for improving management of sunitinib-induced hypertension in rats","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:14:32Z","timestamp":1776460472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":27,"alternative-id":["S0753332223013021"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115504","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenesis inhibitor-specific hypertension increases the risk of developing aortic dissection","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115504"}}